Symbiotic Health

Symbiotic Health is a New York-based biotechnology company specializing in the oral delivery of biologics and vaccines through an engineered microbiome platform. The company utilizes commensal bacteria, specifically from the genus Bacteroides, to act as in situ production factories for therapeutic proteins within the human gastrointestinal tract. This technology aims to convert traditionally injectable treatments, such as monoclonal antibodies and vaccines, into stable oral capsules that target the gut directly. Their current pipeline includes programs for the prevention of Clostridioides difficile infection and the treatment of inflammatory bowel disease. By leveraging the natural stability and colonization properties of gut commensals, Symbiotic Health seeks to improve the efficacy and accessibility of complex biologic therapies.